Mind-blowing Ipbt-5ca (ibc-293), Gpr109b Agonist (tbi1070) Save 50% + Free Ship [zAkJZg03]

Superior GPR109B Agonist - IPBT-5CA (IBC-293)

Introducing IPBT-5CA (IBC-293), a cutting-edge GPR109B agonist that represents a significant advancement in drug discovery and research. This highly selective compound is designed to activate the human orphan G-protein-coupled receptor GPR109b, offering researchers a powerful tool for exploring novel therapeutic targets. With its impressive EC50 value of 400 nM and negligible activity at the closely related GPR109a receptor, IPBT-5CA stands out as a unique and potent agonist. The product boasts an impressive purity of >98%, ensuring reliable and consistent results in various experimental settings.

Product Specifications and Benefits

IPBT-5CA is formally known as 1-(1-Methylethyl)-1H-benzotriazole-5-carboxylic acid, and its molecular formula is C₁₀H₁₁N₂O₂, with a formula weight of 205.22. This compound is available as a high-quality powder, with a storage stability of ≥ 2 years at room temperature (RT). Its solubility in DMSO is exceptional, reaching up to 25 mg/ml, making it easy to dissolve and handle in various experimental procedures. This product is perfect for researchers seeking a reliable and potent agonist for GPR109b with a broad range of potential applications.

• High purity >98%
• Superior solubility in DMSO
• Stable at room temperature for ≥ 2 years

Applications and Target Markets

The versatile nature of IPBT-5CA makes it a valuable asset for researchers in various fields. Its selective agonism at the GPR109b receptor opens up opportunities for studying metabolic diseases, cardiovascular disorders, and inflammatory conditions. This compound can be used in cell-based assays, in vivo models, and various preclinical studies. Whether you are a researcher in academia, pharmaceutical industry, or biotechnology sector, IPBT-5CA offers a robust solution for advancing your research goals. With its precision and reliability, this product is the ideal choice for those who demand excellence in their research tools.

• Metabolic disease research
• Cardiovascular disorder studies
• Inflammatory condition investigation